HiWebsite

Website Overview: fasenra.comopen_in_new

General information

Last Updated: 2024-04-13 (yyyy-mm-dd).

Title: Severe Eosinophilic Asthma Treatment FASENRA benralizumab Subcutaneous Injection 30mg

Description: FASENRA benralizumab is an add on maintenance treatment for patients 12 and older who are diagnosed with severe eosinophilic asthma

Fasenra.com Screenshot 2024-07-05 07:15:25

Language: English

Contact information

Telephone

Social Links

Services and technology that the website used

Vendor

Related Websites